Search: onr:"swepub:oai:prod.swepub.kib.ki.se:131613016" > Efficacy and safety...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 01536naa a2200385 4500 | |
001 | oai:prod.swepub.kib.ki.se:131613016 | |
003 | SwePub | |
008 | 240829s2015 | |||||||||||000 ||eng| | |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1316130162 URI |
024 | 7 | a https://doi.org/10.1136/annrheumdis-2014-2070902 DOI |
040 | a (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Smolen, JS4 aut |
245 | 1 0 | a Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study |
264 | c 2015-04-14 | |
264 | 1 | b BMJ,c 2015 |
700 | 1 | a Weinblatt, ME4 aut |
700 | 1 | a van der Heijde, D4 aut |
700 | 1 | a Rigby, WFC4 aut |
700 | 1 | a van Vollenhoven, Ru Karolinska Institutet4 aut |
700 | 1 | a Bingham, CO4 aut |
700 | 1 | a Veenhuizen, M4 aut |
700 | 1 | a Gill, A4 aut |
700 | 1 | a Zhao, FY4 aut |
700 | 1 | a Komocsar, WJ4 aut |
700 | 1 | a Berclaz, PY4 aut |
700 | 1 | a Ortmann, R4 aut |
700 | 1 | a Lee, C4 aut |
710 | 2 | a Karolinska Institutet4 org |
773 | 0 | t Annals of the rheumatic diseasesd : BMJg 74:8, s. 1567-1570q 74:8<1567-1570x 1468-2060x 0003-4967 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:131613016 |
856 | 4 8 | u https://doi.org/10.1136/annrheumdis-2014-207090 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.